Rémi Diesler

ORCID: 0000-0003-0746-357X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Medical Imaging and Pathology Studies
  • Tuberous Sclerosis Complex Research
  • Neonatal Respiratory Health Research
  • Pulmonary Hypertension Research and Treatments
  • Systemic Sclerosis and Related Diseases
  • Inflammatory Myopathies and Dermatomyositis
  • Sarcoidosis and Beryllium Toxicity Research
  • Histiocytic Disorders and Treatments
  • Occupational and environmental lung diseases
  • Vascular Anomalies and Treatments
  • Congenital Diaphragmatic Hernia Studies
  • Corporate Governance and Law
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Vascular Tumors and Angiosarcomas
  • Cardiovascular Issues in Pregnancy
  • Neuroscience of respiration and sleep
  • Streptococcal Infections and Treatments
  • Infectious Diseases and Mycology
  • Bacterial Identification and Susceptibility Testing
  • Plant and Fungal Interactions Research
  • Diphtheria, Corynebacterium, and Tetanus
  • Extracellular vesicles in disease
  • Neuroblastoma Research and Treatments

Hospices Civils de Lyon
2021-2025

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
2021-2025

Hôpital Louis Pradel
2020-2025

Université Claude Bernard Lyon 1
2022-2025

Harvard University
2024-2025

Brigham and Women's Hospital
2025

École Pratique des Hautes Études
2024

Laboratoire National de Référence
2022

Hôpital de la Croix-Rousse
2021

Background: Antibodies against Ku have been described in patients with various connective tissue diseases. The objective of this study was to describe the clinical, functional, and imaging characteristics interstitial lung disease anti-Ku antibodies. Methods: This single-center, retrospective observational conducted at a tertiary referral institution. Patients positive antibodies identified between 2007 2022 were included. Clinical, immunological, data systematically reviewed. Results:...

10.3390/jcm14010247 article EN Journal of Clinical Medicine 2025-01-03

LAM is a rare multi-cystic lung disease for which treatment with sirolimus indicated in cases of moderate or severe declining function. The aim this study was to describe patients treated and their outcomes. This retrospective observational based on data from the French national health insurance system (SNDS). All adult women receiving were identified France between 2014 2021. In absence specific code system, an algorithm developed identify possible exclusion other indications...

10.3389/fmed.2024.1494713 article EN cc-by Frontiers in Medicine 2025-01-08

<title>Abstract</title> Pulmonary lymphangioleiomyomatosis (LAM) is metastatic sarcoma but mechanisms of LAM metastasis are unknown. Extracellular vesicles (EV) regulate cancer their roles in have not yet been thoroughly investigated. Here, we report the discovery distinct LAM-EV subtypes derived from primary tumor or metastasizing cells that promote through ITGα6/β1-c-Src-FAK signaling, triggered by shuttling ATP synthesis to cell pseudopodia activation integrin adhesion complex,...

10.21203/rs.3.rs-5390547/v1 preprint EN cc-by Research Square (Research Square) 2025-03-20

Diffuse interstitial lung diseases (ILD) constitute a heterogeneous group of conditions with complex etiological diagnoses requiring multidisciplinary approach. Much is still unknown about them, particularly their relationship occupational exposures. The primary objective this study was to investigate the distribution exposures according type ILD. secondary objectives were estimate proportion ILDs possibly related exposure and evaluate added value participation an disease consultant in ILD...

10.1186/s12931-022-02257-6 article EN cc-by Respiratory Research 2022-12-08

Abstract Background and Objective Variants in surfactant genes SFTPC or ABCA3 are responsible for interstitial lung disease (ILD) children adults, with few studies adults. Methods We conducted a multicentre retrospective study of all consecutive adult patients diagnosed ILD associated variants the French rare pulmonary diseases network, OrphaLung. chest computed tomography (CT) features were centrally reviewed. Results included 36 (median age: 34 years, 20 males), 22 group 14 group. Clinical...

10.1111/resp.14667 article EN cc-by-nc-nd Respirology 2024-02-12

Pulmonary alveolar proteinosis (PAP) is characterized by the accumulation of lipoproteins in pulmonary alveoli due to defective clearance macrophages [1]. It may be associated with myriad immune, metabolic, and infectious diseases. In adults, autoimmune PAP anti–granulocyte-macrophage colony stimulating factor (GM-CSF) antibodies. children, hereditary biallelic mutations CSF2RA (MIM 306250) CSF2RB 138981) encoding alpha or beta chains, respectively, GM-CSF receptor. Footnotes This manuscript...

10.1183/23120541.00472-2023 article EN cc-by-nc ERJ Open Research 2023-09-28

ENTV (Enzootic Nasal Tumor Virus) and JSRV (Jaagsiekte Sheep Retrovirus) are β-retroviruses responsible for respiratory cancers in sheep goats. In this study, we analyzed the genetic features of goat β-Retroviruses (29 24 strains) circulating France to identify molecular signatures associated with disease severity flocks.

10.3389/fcimb.2024.1466333 article EN cc-by Frontiers in Cellular and Infection Microbiology 2024-11-08

Mutations in the Tuberous Sclerosis Complex (TSC) genes result hyperactivation of mechanistic/mammalian target rapamycin 1 (mTORC1) growth pathway mesenchymal pulmonary cells. Rapamycin (Sirolimus

10.1165/rcmb.2024-0242oc article EN American Journal of Respiratory Cell and Molecular Biology 2024-11-12

Background. Antibodies against Ku have been described in patients with various connective tissue diseases. The objective of this study was to describe the clinical, functional and imaging characteristics interstitial lung disease anti-Ku antibodies. Methods. This single-center, retrospective observational conducted at a tertiary referral institution. Patients positive antibodies disease, identified between 2007 2022 were included. Clinical, immunological, functional, data systematically...

10.20944/preprints202412.0088.v1 preprint EN 2024-12-02

Background Interstitial lung disease (ILD) is rarer in children (chILD) than adults, but with increasing diagnostic awareness, more cases are being discovered. chILD prognosis often poor, numbers now surviving into adulthood. Aim To characterize chILD-survivors and identify their impact on adult-ILD centers. Methods European study (34 centers) reporting incident/prevalent of from January to July 2023. Epidemiological, clinical, physiological genetic data were collected. Results 244 patients...

10.1183/13993003.00680-2024 article EN publisher-specific-oa European Respiratory Journal 2024-12-05

10.1016/s1155-195x(23)92212-7 article FR Encyclopédie médico-chirurgicale. Pneumologie 2024-01-01

<b>Introduction:</b>&nbsp;Mutations in surfactant genes SFTPC or ABCA3 are responsible for interstitial lung disease (ILD) children and adults. Despite numerous paediatric data, few studies described these entities <b>Methods:</b>&nbsp;We conducted a multicenter retrospective study of adult patients with ILD associated mutations the French rare pulmonary diseases network OrphaLung. <b>Results:</b>&nbsp;We included 36 patients, 22 <i>SFTPC</i> group 14 <i>ABCA3</i> group. Clinical...

10.1183/13993003.congress-2023.oa3280 article EN 2023-09-09

We report here the case of a 49-year-old man admitted for diagnostic work-up bilateral lung nodules. Empyema rapidly developed after chest computed-tomodensitometry guided puncture. Despite lack obvious aetiology two biopsies, diagnosis was reached by performing 16S ribosomal DNA (rDNA) sequence analysis, which identified Prevotella spp in pleural liquid. The empyema and nodules resolved appropriate antibiotic therapy.

10.1016/j.rmcr.2021.101567 article EN cc-by-nc-nd Respiratory Medicine Case Reports 2021-12-15
Coming Soon ...